You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA Mutations

Showing 1 - 25 of 2,781
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Metastatic Trial in Beijing (TSL-1502 capsules(low dose), TSL-1502 capsules(high dose), Investigator's choice of

Not yet recruiting
  • Breast Cancer Metastatic
  • TSL-1502 capsules(low dose)
  • +2 more
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jun 13, 2022

Hot Flashes, Menopause Surgical Trial in Jerusalem (Acupuncture, Acupuncture-Acupressure)

Not yet recruiting
  • Hot Flashes
  • Menopause Surgical
  • Acupuncture
  • Acupuncture-Acupressure
  • Jerusalem, Israel
    Center for Integrative Complementary Medicine, Shaare Zedek Medi
Oct 24, 2022

Ovarian Reserve in Premenopausal Early-stage Breast Cancer or

Recruiting
  • Breast Cancer
  • Blood draw and questionnaires
  • Basking Ridge, New Jersey
  • +7 more
Jan 19, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Ovarian Cancer Trial in Vandœuvre-lès-Nancy (HRD and BRCA mutations)

Completed
  • Ovarian Cancer
  • HRD and BRCA mutations
  • Vandœuvre-lès-Nancy, France
    Institut de Cancerologie de Lorraine
Mar 29, 2022

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Apr 8, 2023

Clinical Significance of Germline BRCA Mutations

Recruiting
  • Breast Cancer
  • Ovarian Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Oct 6, 2021

    Breast Cancer After Ovarian Cancer During and/or After Therapy:

    Recruiting
    • BRCA-Associated Breast Carcinoma
    • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Mar 9, 2023

    Searching for Novel Germline Mutations in Lobular Breast Cancer

    Recruiting
    • Lobular Breast Carcinoma
    • +3 more
    • Illumina panel
    • Milan, Italy
      European Institute of Oncology
    Sep 12, 2022

    Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)

    Recruiting
    • Metastatic or Unresectable Melanoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
    Mar 22, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

    Recruiting
    • BRCA1 Gene Mutation
    • BRCA2 Gene Mutation
    • Informational Intervention
    • Survey Administration
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Mar 2, 2022

    Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 Trial in Stockholm (Mifepristone)

    Completed
    • Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
    • Stockholm, Sweden
      Department of Woman and Child Health Karolinska University Hospi
    Jan 15, 2022

    Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by

    Completed
    • Breast Cancer
    • Blood test
    • Questionnaire
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 27, 2021

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 28, 2022

    Breast Cancer Trial in Worldwide (Neoadjuvant Olaparib monotherapy group, Neoadjuvant combination therapy with olaparib plus

    Not yet recruiting
    • Breast Cancer
    • Neoadjuvant Olaparib monotherapy group
    • Neoadjuvant combination therapy with olaparib plus durvalumab
    • Wien, Austria
    • +6 more
    Aug 10, 2022

    Germline Mutations Associated With Hereditary Pancreatic Cancer

    Recruiting
    • Pancreatic Cancer
    • Pancreatic Adenocarcinoma
    • Invitae Multi-Cancer Panel ®
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Mar 22, 2022

    Advanced Ovarian Cancer, Primary Peritoneal Cancer, Advanced Breast Cancer Trial run by the NCI (BMN 673)

    Completed
    Has Results
    • Advanced Ovarian Cancer
    • +3 more
    • BMN 673
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Feb 2, 2021

    Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)

    Active, not recruiting
    • Hereditary Breast and Ovarian Cancer
    • Structured exercise training plus mediterranean diet
    • Cologne, Germany
    • +2 more
    Oct 25, 2022

    Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

    Not yet recruiting
    • Recurrent Metastatic Melanoma
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Jul 29, 2022

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    Breast Cancer Trial in New York (core needle biopsy, blood draw)

    Recruiting
    • Breast Cancer
    • core needle biopsy
    • blood draw
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Nov 9, 2023

    ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

    Recruiting
    • ARID1A Gene Mutation
    • +15 more
    • Scottsdale, Arizona
    • +4 more
    Dec 13, 2022

    Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

    Not yet recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • Biospecimen Collection
    • +6 more
    • (no location specified)
    Mar 28, 2023

    NSCLC Trial in Badalona, Málaga (Docetaxel, Cisplatin, Gemcitabine)

    Completed
    • Non-small Cell Lung Cancer
    • Badalona, Barcelona, Spain
    • +1 more
    Jun 8, 2022